Winston Pharmaceuticals, Inc.
WPHM
$0.00
$0.000.00%
OTC PK
| 03/31/2010 | 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | |
|---|---|---|---|---|---|
| Net Income | -460.70K | -561.90K | -702.50K | -612.10K | -778.80K |
| Total Depreciation and Amortization | 2.10K | 2.20K | 2.20K | 2.30K | 2.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 37.40K | 38.40K | 29.10K | 26.70K | -- |
| Change in Net Operating Assets | -462.20K | -242.90K | -155.10K | -485.70K | -762.90K |
| Cash from Operations | -883.40K | -764.30K | -826.20K | -1.07M | -1.54M |
| Capital Expenditure | -- | 0.00 | 0.00 | 0.00 | -700.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.90K | 900.00 | -- | -- | -- |
| Cash from Investing | -1.90K | 900.00 | 0.00 | 0.00 | -700.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 7.00K | 0.00 | 44.50K | 83.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 7.00K | 0.00 | 44.50K | 83.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -885.30K | -756.40K | -826.20K | -1.02M | -1.46M |